The La Jolla Playhouse is gearing up for its annual DNA New Work Series, an event that has become a cornerstone of the theater's commitment to nurturing emerging talent. This year, however, marks a significant shift with the arrival of a new artistic director, Jessica Stone, who takes the reins from the esteemed Christopher Ashley.
Under Stone's leadership, the DNA New Work Series promises to continue its tradition of supporting playwrights and their creative processes, but with a fresh perspective. One thing that immediately stands out to me is the series' unique approach to presenting new works. Instead of grand productions, the focus is on intimate readings, allowing audiences to connect with writers and their stories at a vulnerable, early stage of development.
Gabriel Greene, the director of artistic development, curates the series with a threefold philosophy: matching resources with projects, fostering artist relationships, and engaging audiences in the play-making process. This approach, in my opinion, is a brilliant way to encourage collaboration and support the artistic journey.
The selected plays for this year's series showcase a range of themes and stories. From the tentative friendship in "Rockville" to the intense mother-daughter relationship in "Evil Diva", these works delve into the complexities of human connections. What makes this particularly fascinating is the way Greene highlights the molecular exploration of one-on-one relationships as a common thread, offering a deeper insight into the human condition.
One detail that I find especially interesting is the change in the series' timing, moving from December to May. Greene's reasoning is practical yet insightful, acknowledging the challenges of the holiday season and the convenience of May for seasonal programming. This shift, I believe, demonstrates a thoughtful consideration of the audience's needs and the artists' schedules.
With Stone at the helm, the future of the DNA New Work Series looks bright. Her enthusiasm for expanding the playhouse's commitment to new plays and musicals is a welcome development. As an observer, I'm excited to see how her vision will shape the series and inspire future productions.
The DNA New Work Series is not just an event; it's a platform that has launched many successful plays, including works by Pulitzer Prize winners. This year's lineup, with its diverse themes and talented directors, promises to continue this tradition of excellence.
As we look forward to the readings in May, it's clear that the La Jolla Playhouse remains a vital hub for artistic development and innovation. Personally, I think this series is a testament to the power of theater as a collaborative art form and its ability to foster creativity and connection.
